{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:ERK",
      "entity_text" : "MAPK",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01140",
      "entity_text" : "cetuximab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We have confirmed that cetuximab inhibited the EGFR / MAPK pathway and reduced tumor growth in the xenografts while the remaining tumor showed EGFR pathway activation.",
  "reading_complete" : "2020-08-02T11:10:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T11:07:57Z",
  "trigger" : "inhibited",
  "evidence" : [ "cetuximab inhibited the EGFR/MAPK" ],
  "pmc_id" : "3118158",
  "score" : 0
}